기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
HMGB1 Promotes the Synthesis of Pro-IL-1β and Pro-IL-18 by Activation of p38 MAPK and NF-κB Through Receptors for Advanced Glycation End-products in Macrophages
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • HMGB1 Promotes the Synthesis of Pro-IL-1β and Pro-IL-18 by Activation of p38 MAPK and NF-κB Through Receptors for Advanced Glycation End-products in Macrophages
  • HMGB1 Promotes the Synthesis of Pro-IL-1β and Pro-IL-18 by Activation of p38 MAPK and NF-κB Through Receptors for Advanced Glycation End-products in Macrophages
저자명
He. Qiang,You. Hong,Li. Xin-Min,Liu. Tian-Hui,Wang. Ping,Wang. Bao-En
간행물명
Asian Pacific journal of cancer prevention : APJCP
권/호정보
2012년|13권 4호|pp.1365-1370 (6 pages)
발행정보
아시아태평양암예방학회
파일정보
정기간행물|ENG|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

The high mobility group box-1 (HMGB1) protein and NALP3 inflammasome have been identified to play important roles in inflammation and cancer pathogenesis, but the relationships between the two and cancer remain unclear. The current study investigated the relationship between HMGB1 and the NALP3 inflammasome in THP-1 macrophages. HMGB1 was found unable to activate the NALP3 inflammasome and failed to induce the release of the IL-$1{eta}$ and IL-18 in THP-1 macrophages. HMGB1 was also found significantly enhanced the activity of ATP to induce IL-$1{eta}$ and IL-18 by the induction of increased expression of pro-IL-$1{eta}$ and pro-IL-18. This process was dependent on activation of RAGE, MAPK p38 and NF-${kappa}B$ signaling pathway. These results demonstrate that HMGB1 promotes the synthesis of pro-IL-$1{eta}$ and pro-IL-18 in THP-1 macrophages by the activation of p38 MAPK and NF-${kappa}B$ through RAGE. HMGB1 likely plays an important role in the first step of the release of the IL-$1{eta}$ and IL-18, preparing for other cytokines to induce excessive release of IL-$1{eta}$ and IL-18 which promote inflammation and cancer progression.